Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of SeeMore (TM) in Heart Patients

This study has been completed.
Information provided by (Responsible Party):
Eagle Vision Pharmaceutical Corp. Identifier:
First received: April 14, 2009
Last updated: February 3, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)